IS-065 Hemangiomas: Oral Propanolol And Beyond
نویسندگان
چکیده
منابع مشابه
Propanolol Hydrochloride Oral Solution
Inactive Ingredients Propranolol Hydrochloride Oral Solution is available for oral administration containing either 20 mg per 5 mL or 40 mg per 5 mL of propranolol hydrochloride USP. The oral solution contains the following inactive ingredients: citric acid anhydrous, crème de menthe flavor, disodium edetate, methyl paraben, propylene glycol, propylparaben, purified water, saccharin sodium, sor...
متن کاملCD105 expression in oral capillary hemangiomas and cavernous hemangiomas.
Capillary hemangioma (capillary lobular hemangioma) and cavernous hemangioma (venous malformation) are relatively common oral tumors/malformations and are characterized by increased numbers of normal and abnormal blood vessels. However, the causes of these lesions are not well understood. CD105 (endoglin) is predominantly expressed in proliferating blood endothelial cells (ECs). We analyzed exp...
متن کاملThe Effect of Oral Propranolol versus Oral Corticosteroids in Management of Pediatric Hemangiomas
BACKGROUND Hemangiomas are the most common benign tumors of infancy. This study evaluated the efficacy of oral propranolol comparing to oral steroids in management of pediatric hemangiomas. METHODS In North India from January 2012 to January 2015, sixty children <6 years old with superficial hemangiomas were divided into 2 groups; oral propranolol vs. oral prednisolone. All participants we...
متن کاملOral corticosteroid use is effective for cutaneous hemangiomas: an evidence-based evaluation.
OBJECTIVES To determine the efficacy of systemic corticosteroid therapy in treating enlarging, problematic cutaneous hemangiomas and to assess the relationship of dose to response and adverse effects. DESIGN A quantitative systematic literature review was performed and inclusion and exclusion criteria were applied. SETTING Patients were treated in primary care, referral centers, and institu...
متن کاملOral propranolol for treatment of periocular infantile hemangiomas.
OBJECTIVE To evaluate the efficacy and adverse effects of oral propranolol for treatment of periocular infantile hemangioma. METHODS Participants were treated with oral propranolol 3 times daily, with outpatient monitoring of adverse effects. The starting dosage was 0.5 mg/kg/d for 1 week, then 1 mg/kg/d for the following week, then 2 mg/kg/d for the remaining duration of treatment. Serial ex...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Archives of Disease in Childhood
سال: 2014
ISSN: 0003-9888,1468-2044
DOI: 10.1136/archdischild-2014-307384.65